• Respiratory diseases
  - Pasteurella
  - Mycoplasma hyo.
• Enteric diseases
  - Ileitis
  - Clostridium
  - Salmonella
  - Hemorrhagic bowel
• Reproductive disease
  - Leptospirosis
• Performance
  - Feed efficiency/Gain
  - Variability

Alpharma, LLC, a wholly owned subsidiary of King Pharmaceuticals, is a global animal health company with a leadership position in the development, registration, manufacturing, and marketing of a broad range of pharmaceutical and nutritional products for food producing animals. Alpharma, LLC currently markets over 100 products in more than 80 countries worldwide.

Alpharma remains committed to an aggressive pursuit of technological advances in animal health and to identifying and developing new products that meet all of your needs–safety, convenience, effectiveness, and value.

As a global leader, Alpharma markets over 100 medicated feed additive products and water-soluble therapies that foster health and prevent disease in a wide array of livestock and poultry.

About King Pharmaceuticals

King, an S&P 500 Index company, is a vertically integrated branded pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in specialty-driven markets including neuroscience, hospital and acute care medicines.

King’s business model offers the best qualities of a big and small company in one fully integrated pharmaceutical company. Our size enables us to build close personal relationships with the medical community and flexible collaborative partnerships with other pharmaceutical companies.

Fully integrated resources in scientific and technical operations, coupled with a fully aligned sales force, enable us to move quickly to capitalize on scientific advances and bring innovative medicines and technologies to market.

These strategic competencies, combined with dynamic executive leadership, strategic discipline and financial strength, have established King as a leading specialty pharmaceutical company.